GordonMD Global Investments LP 13D and 13G filings for Kyverna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-17 3:41 pm Purchase | 2025-11-13 | 13G | Kyverna Therapeutics, Inc. KYTX | GordonMD Global Investments LP | 3,058,485 7.000% | 3,058,485 (New Position) | Filing |